Patient-Reported Visual Function Over 24 Months in Predominantly Classic Neovascular AMD: Results From ANCHOR, a Phase III Trial of Ranibizumab and Verteporfin PDT
Year: 2007
Type: article
Authors: Stephen G. Schwartz, N. M. Bressler, Jennifer Fine, Chantal Dolan, Elaine Yu, James Ward, Tom Chang
Institutions: University of Miami, Johns Hopkins University, Genentech
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1190908379
